Your browser doesn't support javascript.
loading
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models.
Tan, Ching Leng; Chan, Yinghan; Candasamy, Mayuren; Chellian, Jestin; Madheswaran, Thiagarajan; Sakthivel, Lakshmana Prabu; Patel, Vyoma K; Chakraborty, Amlan; MacLoughlin, Ronan; Kumar, Deepak; Verma, Nitin; Malyla, Vamshikrishna; Gupta, Piyush Kumar; Jha, Niraj Kumar; Thangavelu, Lakshmi; Devkota, Hari Prasad; Bhatt, Shvetank; Prasher, Parteek; Gupta, Gaurav; Gulati, Monica; Singh, Sachin Kumar; Paudel, Keshav Raj; Hansbro, Philip M; Oliver, Brian G; Dua, Kamal; Chellappan, Dinesh Kumar.
Afiliación
  • Tan CL; School of Health Sciences, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
  • Chan Y; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
  • Candasamy M; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
  • Chellian J; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
  • Madheswaran T; Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
  • Sakthivel LP; Department of Pharmaceutical Technology, University College of Engineering (BIT Campus), Anna University, Tiruchirappalli, 620024, India.
  • Patel VK; Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006, Australia.
  • Chakraborty A; Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.
  • MacLoughlin R; Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland; School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland; School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland.
  • Kumar D; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, 173229, India.
  • Verma N; Chitkara University School of Pharmacy, Chitkara University, Atal Shiksha Kunj, Atal Nagar, Himachal Pradesh, 174103, India.
  • Malyla V; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
  • Gupta PK; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Knowledge Park III, Greater Noida, 201310, Uttar Pradesh, India.
  • Jha NK; Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, Uttar Pradesh, 201310, India.
  • Thangavelu L; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
  • Devkota HP; Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, Kumamoto, 862-0973, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.
  • Bhatt S; Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, 474005, Madhya Pradesh, India.
  • Prasher P; Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.
  • Gupta G; School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India.
  • Gulati M; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India.
  • Singh SK; School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T Road, Phagwara, Punjab, India.
  • Paudel KR; School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia.
  • Hansbro PM; School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia.
  • Oliver BG; School of Life Sciences, University of Technology Sydney, Sydney, NSW, 2007, Australia; Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia.
  • Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia. Electronic address: Kamal.Dua@uts.edu.au.
  • Chellappan DK; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia. Electronic address: dinesh_kumar@imu.edu.my.
Eur J Pharmacol ; 919: 174821, 2022 Mar 15.
Article en En | MEDLINE | ID: mdl-35151643
Chronic respiratory diseases have collectively become a major public health concern and have now taken form as one of the leading causes of mortality worldwide. Most chronic respiratory diseases primarily occur due to prolonged airway inflammation. In addition, critical environmental factors such as cigarette smoke, industrial pollutants, farm dust, and pollens may also exacerbate such diseases. Moreover, alterations in the genetic sequence of an individual, abnormalities in the chromosomes or immunosuppression resulting from bacterial, fungal, and viral infections may also play a key role in the pathogenesis of respiratory diseases. Over the years, multiple in vitro models have been employed as the basis of existing as well as emerging advancements in chronic respiratory disease research. These include cell lines, gene expression techniques, single cell RNA sequencing, cytometry, culture techniques, as well as serum/sputum biomarkers that can be used to elucidate the molecular mechanisms underlying these diseases, and to identify novel diagnostic and management options for these diseases. This review summarizes the current understanding of the pathogenesis of various chronic respiratory diseases derived through in vitro experimental models, where the knowledge obtained from these studies can greatly benefit researchers in the discovery and development of novel screening techniques and advanced therapeutic strategies that could be translated into clinical use in the future.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Modelos Teóricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Modelos Teóricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Países Bajos